178 related articles for article (PubMed ID: 37033441)
1. Galangin delivered by retinoic acid-modified nanoparticles targeted hepatic stellate cells for the treatment of hepatic fibrosis.
Xiong Y; Wu B; Guo X; Shi D; Xia H; Xu H; Liu X
RSC Adv; 2023 Apr; 13(16):10987-11001. PubMed ID: 37033441
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
4. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy.
Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y
Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869
[TBL] [Abstract][Full Text] [Related]
5. Galangin Reverses Hepatic Fibrosis by Inducing HSCs Apoptosis via the PI3K/Akt, Bax/Bcl-2, and Wnt/β-Catenin Pathway in LX-2 Cells.
Xiong Y; Lu H; Xu H
Biol Pharm Bull; 2020 Nov; 43(11):1634-1642. PubMed ID: 32893252
[TBL] [Abstract][Full Text] [Related]
6. miR-146b-5p activation of hepatic stellate cells contributes to the progression of fibrosis by directly targeting HIPK1.
Xie J; Cheng N; Huang Z; Shu X; Xiang T
Exp Ther Med; 2022 Aug; 24(2):537. PubMed ID: 35837064
[TBL] [Abstract][Full Text] [Related]
7. Development of Salvianolic acid B-Tanshinone II A-Glycyrrhetinic acid compound liposomes: formulation optimization and its effects on proliferation of hepatic stellate cells.
Lin J; Wang X; Wu Q; Dai J; Guan H; Cao W; He L; Wang Y
Int J Pharm; 2014 Feb; 462(1-2):11-8. PubMed ID: 24374609
[TBL] [Abstract][Full Text] [Related]
8. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
[TBL] [Abstract][Full Text] [Related]
9. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
Younis N; Shaheen MA; Abdallah MH
Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effect of Polymeric Nanomicelles Formulation of LY2157299-Galunisertib on CCl
Panzarini E; Leporatti S; Tenuzzo BA; Quarta A; Hanafy NAN; Giannelli G; Moliterni C; Vardanyan D; Sbarigia C; Fidaleo M; Tacconi S; Dini L
J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579532
[TBL] [Abstract][Full Text] [Related]
11. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
[TBL] [Abstract][Full Text] [Related]
12. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
13. Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells.
Xia S; Liu Z; Cai J; Ren H; Li Q; Zhang H; Yue J; Zhou Q; Zhou T; Wang L; Liu X; Zhou X
J Control Release; 2023 Mar; 355():54-67. PubMed ID: 36693527
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatic fibrosis effects of a novel turtle shell decoction by inhibiting hepatic stellate cell proliferation and blocking TGF-β1/Smad signaling pathway in rats.
Bai G; Yan G; Wang G; Wan P; Zhang R
Oncol Rep; 2016 Nov; 36(5):2902-2910. PubMed ID: 27633729
[TBL] [Abstract][Full Text] [Related]
15. Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update.
Zhu S; Chen X; Chen Y; Li XF; Chen SY; Li JJ; Wang A; Huang C; Li J
Curr Pharm Des; 2021; 27(27):3000-3011. PubMed ID: 33100194
[TBL] [Abstract][Full Text] [Related]
16. Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase.
Shajari S; Laliena A; Heegsma J; Tuñón MJ; Moshage H; Faber KN
J Pineal Res; 2015 Oct; 59(3):391-401. PubMed ID: 26308880
[TBL] [Abstract][Full Text] [Related]
17. Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway.
Guo M; Wang Z; Dai J; Fan H; Yuan N; Gao L; Peng H; Cheng X
Phytomedicine; 2023 Apr; 112():154587. PubMed ID: 36805480
[TBL] [Abstract][Full Text] [Related]
18. Fusion protein of retinol-binding protein and albumin domain III reduces liver fibrosis.
Lee H; Jeong H; Park S; Yoo W; Choi S; Choi K; Lee MG; Lee M; Cha D; Kim YS; Han J; Kim W; Park SH; Oh J
EMBO Mol Med; 2015 Jun; 7(6):819-30. PubMed ID: 25864124
[TBL] [Abstract][Full Text] [Related]
19. Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity.
Xue H; Qin L; Zhang L; Li X; Wu F; Wang W; Wang C; Diao W; Jiang B; Lian B; Wu J; Bai J; Sun T; Zhao C; Qu M; Yu W; Wang Y; Gao Z
Exp Ther Med; 2021 Oct; 22(4):1144. PubMed ID: 34471430
[TBL] [Abstract][Full Text] [Related]
20. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis.
Ohata M; Lin M; Satre M; Tsukamoto H
Am J Physiol; 1997 Mar; 272(3 Pt 1):G589-96. PubMed ID: 9124579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
